OncologyDiscovery
Solid tumors
Aviceda’s powerful technology centers on presenting high-affinity ligands to expose and unmask cancer cells to increase the cytotoxicity of the immune cells (i.e., natural killer, macrophages, T-cells) in the tumor micro-environment to attack and eliminate cancer.
